A Plus Biotechnology (6918.TWO) Earnings Analysis
A Plus Biotechnology (6918.TWO) has no confirmed upcoming earnings date. Trailing P/E 14.21.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6918.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 6918.TWO. This page updates as the calendar is published.
6918.TWO earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
6918.TWO valuation and analyst view
| Trailing P/E | 14.21 |
|---|---|
| Trailing EPS | 5.057 TWD |
| Price / book | 2.19 |
| Dividend yield | 6.86% |
| Market cap | 2.48B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is A Plus Biotechnology (6918.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 6918.TWO. This page updates as the calendar is published.
What is 6918.TWO's current P/E ratio and EPS?
6918.TWO trades at a trailing P/E of 14.21 on trailing EPS of 5.056515783030692 TWD.
What do analysts rate 6918.TWO?
6918.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.